Evidence map›Paper›PMID 40646453›Full record

ArticleBMC infectious diseases2025

Barriers and facilitators of COVID-19 vaccination among drug users: a qualitative analysis for future crisis management.

Salah Eddin Karimi, Sina Ahmadi, Neda SoleimanvandiAzar, Zahra Rampisheh, Marzieh Nojomi, Elham Sepahvand, Fateh Tavangar, Seyed Arash Tehrani-Banihashemi, Batool Tayefi, Peter Higgs

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Salah Eddin KarimiSocial Determinants of Health Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID http://orcid.org/0000-0002-1542-0214
Sina AhmadiSocial Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID http://orcid.org/0000-0002-7553-8206
Neda SoleimanvandiAzarPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, P.O Box: 14665-354, Shahid Hemmat Highway, Tehran, 1449614535, Iran. Soleimanvandi.n@iums.ac.ir.ORCID http://orcid.org/0000-0002-9840-5588
Zahra RampishehPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, P.O Box: 14665-354, Shahid Hemmat Highway, Tehran, 1449614535, Iran.ORCID http://orcid.org/0000-0002-6401-9654
Marzieh NojomiPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, P.O Box: 14665-354, Shahid Hemmat Highway, Tehran, 1449614535, Iran.ORCID http://orcid.org/0000-0003-4330-3522
Elham SepahvandDepartment of Nursing, School of Nursing and Midwifery, Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.ORCID http://orcid.org/0000-0001-7224-8601
Fateh TavangarSocial Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID http://orcid.org/0000-0002-4815-9294
Seyed Arash Tehrani-BanihashemiPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, P.O Box: 14665-354, Shahid Hemmat Highway, Tehran, 1449614535, Iran.ORCID http://orcid.org/0000-0001-6911-9817
Batool TayefiPreventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, P.O Box: 14665-354, Shahid Hemmat Highway, Tehran, 1449614535, Iran.ORCID http://orcid.org/0000-0002-0913-7324
Peter HiggsDepartment of Public Health, La Trobe University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-5587-5379

Funding

Iran University of Medical Sciences,Iran 1401-1-90-23238
6 · The paper itself

Abstract

introductionPeople Who Use Drugs (PWUD), are a population at the high risk of exposure to infectious disease and should be considered as a priority for vaccination against communicable diseases. However, during the COVID-19 pandemic this population showed resistance to vaccination. The aim of this study was to better understand the barriers and facilitators of COVID-19 vaccination in PWUD in Tehran, Iran. MATERIALS AND

methodsIn this qualitative study data were collected through semi-structured interviews with participants through purposeful sampling with maximum variation. The collected data were analyzed using content analysis informed by Graneheim and Lundman using MAXQDA-10 Software. Lincoln and Guba's criteria were used to ensure the accuracy and validity of the data.

findingsOur study results were presented under two main themes: barriers and facilitators to COVID-19 vaccination acceptance among PWUD. Based on the results of this study, the most important barriers to COVID-19 vaccine acceptance were; Stereotyped beliefs (The belief that drug users will not get infected with COVID-19, Ineffectiveness of COVID-19 vaccine, The negative effect of vaccine on underlying disease, Lack of trust in healthcare system and the type of vaccine), Low health literacy and knowledge (Neglecting health and underestimating the disease, Not prioritizing the health, Low health literacy, Believing in self-treatment and traditional medicine, Available rumors), low social capital(including having limited social networks, believing misinformation and perceived powerlessness), Structural and Experiential Barriers (Lack of access to vaccine, Unpleasant past experiences in related with the vaccination), and fear and worry caused by previous experiences(Death or illness of friends/people around who had been vaccinated, Fear of the vaccine). In addition, the most important facilitators of COVID-19 vaccine acceptance can also be classified into 2 categories of The role of incentives and social responsibility(Incentive payments, Social responsibility, Immune system strengthening as a motivation for vaccination) and Rebuilding Trust and Improving Public Perceptions (Compensating for past mistakes, The effect of advertisement by physicians and officials).

conclusionGiven the possibility of future pandemics the role of vaccination in the prevention and control of communicable diseases, it is imperative to reduce the most negative consequences of pandemics for the general public and high-risk groups. Barriers to vaccination can be minimized through effective engagement with different social groups the goal of which is to effectively explain the benefits of vaccination. When planned and implemented well this will maintain health and prevent deaths in future pandemics. Health care policymakers can use the results of this study to reduce the barriers to vaccination and encourage high risk social groups to receive vaccination in future pandemics.

Indexed as

COVID-19COVID-19 VaccinesDrug UsersPatient Acceptance of Health CareVaccinationAdultFemaleHealth Knowledge, Attitudes, PracticeHumansIranMaleMiddle AgedQualitative ResearchSARS-CoV-2Vaccination HesitancyYoung AdultCOVID-19 VaccinesAddictionCOVID-19Drug abusePandemicPeople who use drugsPWUDQualitative studySubstance useVaccine

Identifiers

PMID40646453
PMCPMC12247198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.